Silverback Therapeutics, Inc. announced Thilo Schroeder, Ph.D. will not stand for re-election as a member of the company's board of directors when his term as a class II director expires at the company's 2022 annual meeting of stockholders and on March 14, 2022, Dr. Schroeder resigned as a member of the audit committee of the board of directors of the company to focus on other endeavors.